This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Raacsh W, Schafer U, Chun J & Dominiak P. Biological significance of agmatine, an endogenous ligand at imidazoline binding sites. Br J Pharmacol. 2001; 133, 755-780.10.1038/sj.bjp.070415311454649RaacshWSchaferUChunJ&DominiakPBiological significance of agmatine, an endogenous ligand at imidazoline binding sitesBr J Pharmacol2001133755780Open DOISearch in Google Scholar
Aricioglu-kartal F & Uzbay IT. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats. Life Sci.1997; 61, 1775-1881.10.1016/S0024-3205(97)00801-19365224Aricioglu-kartalF&UzbayITInhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent ratsLife Sci19976117751881Open DOISearch in Google Scholar
Regunathan S, Youngson C, RaascH W, Wang H & Reis DJ. Imidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation. J Pharmacol Exp Ther. 1996; 276, 1272-1282.8786560RegunathanSYoungsonCRaascHWWangH&ReisDJImidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferationJ Pharmacol Exp Ther199627612721282Search in Google Scholar
Gilad GM, Gilad VH & Rabey JM. Arginine and ornithine decarboxylation in rodent brain: coincidental changes during development and after ischemia. Neurosi Lett 1996; 216, 33-36.10.1016/0304-3940(96)12996-7GiladGMGiladVH&RabeyJMArginine and ornithine decarboxylation in rodent brain: coincidental changes during development and after ischemiaNeurosi Lett19962163336Open DOISearch in Google Scholar
Olmos G, Degregorio-Rocasolano N, Paz RM, Gasull T, Assumpcio BM, Trullas R, Villarroel A, Lerma J & Garcia-Sevilla JA. Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br J Pharmacol. 1999; 127,1317-1326.1045528110.1038/sj.bjp.0702679OlmosGDegregorio-RocasolanoNPazRMGasullTAssumpcioBMTrullasRVillarroelALermaJ&Garcia-SevillaJAProtection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptorBr J Pharmacol199912713171326Search in Google Scholar
Reis DJ & Regunathan S. Is agmatine a novel neurotransmitter in brain? TiPS. 2000; 21, 187-193.ReisDJ&RegunathanSIs agmatine a novel neurotransmitter in brain?TiPS20002118719310.1016/S0165-6147(00)01460-7Search in Google Scholar
Goracke-Postle CJ, Overland AC, Riedl MS, Stone LS, Fairbanks CA. Potassium-and capsaicin-induced release of agmatine from spinal nerve terminals. J. Neurochem. 2007 Sep;102(6):1738-48.10.1111/j.1471-4159.2007.04647.x17539920Goracke-PostleCJOverlandACRiedlMSStoneLSFairbanksCAPotassium-and capsaicin-induced release of agmatine from spinal nerve terminalsJ. Neurochem20071026173848Open DOISearch in Google Scholar
Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, & Reis DJ. Agmatine: an endogenous clonidine-displacing substance in the brain. Science. 1994; 263:966-9.10.1126/science.79060557906055LiGRegunathanSBarrowCJEshraghiJCooperR&ReisDJAgmatine: an endogenous clonidine-displacing substance in the brainScience19942639669Open DOISearch in Google Scholar
Tesson F, Prip-Buus C, Lemoine A, Pegorier JP, Parini A. Subcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liver. Major localization to the mitochondrial outer membrane. J Biol Chem. 1991; 266:155-60.TessonFPrip-BuusCLemoineAPegorierJPPariniASubcellular distribution of imidazoline-guanidinium-receptive sites in human and rabbit liverMajor localization to the mitochondrial outer membrane. J Biol Chem19912661556010.1016/S0021-9258(18)52415-7Search in Google Scholar
Tesson F, Prip-Buus C, Lemoine A, Pegorier JP & Parini A. Characterization of mitochondrial imidazoline-guanidinium receptive sites (IGRS) in liver. Am J Hypertens. 1995; 5, 805-825.TessonFPrip-BuusCLemoineAPegorierJP&PariniACharacterization of mitochondrial imidazoline-guanidinium receptive sites (IGRS) in liverAm J Hypertens1995580582510.1093/ajh/5.4.80S1317714Search in Google Scholar
Raddatz R, Parini A & Lanier SM. Localization of the imidazoline binding domain on monoamine oxidase. B Mol Pharmacol 1997; 52, 549-553.10.1124/mol.52.4.549RaddatzRPariniA&LanierSMLocalization of the imidazoline binding domain on monoamine oxidaseB Mol Pharmacol1997525495539380016Open DOISearch in Google Scholar
Raddatz R, Savic SL, Bakthavachalam V, Lesnik J, Jasper JR, Mcgrath CR, Parini A, Lanier SM. Imidazoline-binding domains on monoamine oxidase B and subpopulations of enzyme. J Pharmacol Exp Ther 2000; 292, 1135-1145.10688633RaddatzRSavicSLBakthavachalamVLesnikJJasperJRMcgrathCRPariniALanierSMImidazoline-binding domains on monoamine oxidase B and subpopulations of enzymeJ Pharmacol Exp Ther200029211351145Search in Google Scholar
Head GA, & Mayorov DN. Imidazoline receptors, novel agents and therapeutic potential. Cardiovasc Hematol Agents Med Chem. 2006; 4:17-32.1652954710.2174/187152506775268758HeadGA&Mayorov DNImidazoline receptors, novel agents and therapeutic potentialCardiovasc Hematol Agents Med Chem200641732Search in Google Scholar
Raasch W, Muhle H, & Dominiak P. Modulation of MAO activity by imidazoline and guanidine derivatives. Ann N Y Acad Sci. 1999; 881:313-31.1041593210.1111/j.1749-6632.1999.tb09376.xRaaschWMuhleH&DominiakPModulation of MAO activity by imidazoline and guanidine derivativesAnn N Y Acad Sci199988131331Search in Google Scholar
Jones TZ, Giurato L, Guccione S. & Ramsay RR. Interactions of imidazoline ligands with the active site of purified monoamine oxidase A. FEBS J. 2007; 274, 1567-1575.1748020510.1111/j.1742-4658.2007.05704.xJonesTZGiuratoLGuccioneS&RamsayRRInteractions of imidazoline ligands with the active site of purified monoamine oxidase AFEBS J200727415671575Search in Google Scholar
Holt A. & Baker GB. Metabolism of agmatine (clonidine-displacing substance) by diamine oxidase and the possible implications for studies of imidazoline receptors. Prog Brain Res. 1995; 106, 187-197.858465410.1016/S0079-6123(08)61215-7HoltA&BakerGBMetabolism of agmatine (clonidine-displacing substance) by diamine oxidase and the possible implications for studies of imidazoline receptorsProg Brain Res1995106187197Search in Google Scholar
Su RB, Li J, Li X. & Qin BY. Down-regolation of MAO-B activity and imidazoline receptors in rat brain following chromic treatment of morphine. Acta Pharmacol. Sin. 2001; 22, 639-644.SuRBLiJLiX&QinBYDown-regolation of MAO-B activity and imidazoline receptors in rat brain following chromic treatment of morphineActa Pharmacol. Sin200122639644Search in Google Scholar
Ozaita A, Olmos G, Boronat MA, Lizcano JM, Unzeta M. & Garcia-Sevilla JA. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver. Br J Pharmacol. 1997; 121, 901-912.10.1038/sj.bjp.0701214OzaitaAOlmosGBoronatMALizcanoJMUnzetaM&Garcia-SevillaJAInhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liverBr J Pharmacol1997121901912Open DOISearch in Google Scholar
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54.10.1016/0003-2697(76)90527-3942051BradfordMMA rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnal Biochem19767224854Open DOISearch in Google Scholar
Weissbach H, Smith TE, Daly JW, Witkop B, & Udenfriend S. A rapid spectrophotometric assay of mono-amine oxidase based on the rate of disappearance of kynuramine. J Biol Chem. 1960; 235:1160-3.13843767WeissbachHSmithTEDalyJWWitkopB&UdenfriendSA rapid spectrophotometric assay of mono-amine oxidase based on the rate of disappearance of kynuramineJ Biol Chem19602351160310.1016/S0021-9258(18)69497-9Search in Google Scholar
Holt A, Palcic MM. A peroxidase-coupled continuous absorbance plate-reader assay for flavin monoamine oxidases, copper-containing amine oxidases and related enzymes. Nat Protoc. 2006; 1(5):2498-505.10.1038/nprot.2006.402HoltAPalcicMMA peroxidase-coupled continuous absorbance plate-reader assay for flavin monoamine oxidases, copper-containing amine oxidases and related enzymesNat Protoc200615249850517406497Open DOISearch in Google Scholar
Holt A., Sharman D.F., Baker G.B., & Palcic M.M. (1997). A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates. Anal Biochem. 244:384-92.902595610.1006/abio.1996.9911HoltA.SharmanD.F.BakerG.B.&PalcicM.M.1997A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenatesAnal Biochem244384929025956Search in Google Scholar
Tipton KF. Inhibition of monoamine oxidase by substituted hydrazines. Biochem J. 1992; 128:913-9.TiptonKFInhibition of monoamine oxidase by substituted hydrazinesBiochem J1992128913910.1042/bj128091311739104674124Search in Google Scholar
Kim H, Sablin SO, & Ramsay RR. Inhibition of monoamine oxidase A by beta-carboline derivatives. Arch Biochem Biophys. 1997; 337:137-42.10.1006/abbi.1996.97718990278KimHSablinSO&RamsayRRInhibition of monoamine oxidase A by beta-carboline derivativesArch Biochem Biophys1997337137428990278Open DOISearch in Google Scholar
Zomkowski AD, Hammes L, Lin J, Calixto JB, Santos AR, Rodrigues AL. Agmatine produces antidepressant-like effects in two models of depression in mice. Neuroreport. 2002; 13(4):387-91.1193014610.1097/00001756-200203250-00005ZomkowskiADHammesLLinJCalixtoJBSantosARRodriguesALAgmatine produces antidepressant-like effects in two models of depression in miceNeuroreport20021343879111930146Search in Google Scholar
Shopsin B. The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study. Acta Neuropsychiatr. 2013; 25(2):113-8. doi: 10.1111/j.1601-5215.2012.00675.x.10.1111/j.1601-5215.2012.00675.x25287313ShopsinBThe clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot studyActa Neuropsychiatr2013252113810.1111/j.1601-5215.2012.00675.x25287313Open DOISearch in Google Scholar
Laube G, Bernstein HG. Agmatine: multifunctional arginine metabolite and magic bullet in clinical neuroscience? Biochem J. 2017; 474(15):2619-2640.10.1042/BCJ2017000728747403LaubeGBernsteinHGAgmatine: multifunctional arginine metabolite and magic bullet in clinical neuroscience?Biochem J2017474152619264028747403Open DOISearch in Google Scholar
